GoodRx Care vs Ro: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Ro beats GoodRx Care overall, scoring 7.2/10 vs 6.2/10. GoodRx Care is more affordable at $119/mo vs $149/mo. Choose GoodRx Care for users who want fda-approved brand-name glp-1 access at marke. Choose Ro for users who want fda-approved brand-name glp-1 access includin.

A side-by-side comparison of GoodRx Care and Ro covering pricing, scores, medication types, insurance, and more to help you decide.

GoodRx Care

#48 of 48

6.2/10

GoodRx Care was restructured in late 2025 from a pay-per-visit model into a telemedicine subscription: $39/mo intro rate (through January 2026) → $119/mo standard. Medication is priced aggressively: Ozempic/Wegovy $199/mo intro for the first 2 fills, then $349/mo standard. Oral Wegovy pill available at $149-199/mo.

Visit GoodRx Care

Higher Rated

Ro

#44 of 48

7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro

Feature	GoodRx Care	Ro
Our Score	6.2/10	7.2/10
Starting Price	$119/mo	$149/mo
Medication Type	Brand	Brand
Insurance Accepted	Yes	Yes
Best For	Users who want FDA-approved brand-name GLP-1 access at market-leading subscription pricing — $199/mo Wegovy intro, $349/mo standard, plus oral Wegovy pill	Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing
Ranking	#48	#44

Pros & Cons Compared

GoodRx Care

Pros

+2026 subscription rewrite — $119/mo standard membership with medication priced among the lowest on the market
+Wegovy/Ozempic intro pricing ($199/mo for first 2 fills) is market-leading for brand-name access
+Oral Wegovy pill available at $149-199/mo — one of the cheapest oral semaglutide routes
+Insurance accepted — GoodRx's integration with savings cards can stack with coverage

Cons

−Model changed from pay-per-visit to subscription — users expecting à-la-carte pricing should double-check current terms
−Compounded GLP-1s are de-emphasized on current marketing — may no longer be available
−Subscription model means ongoing monthly fee even in maintenance months
−Follow-up clinical care is still basic compared to dedicated GLP-1 platforms

Ro

Pros

+Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
+Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
+Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
+Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available

Cons

−Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
−Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
−Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Our Verdict

Ro edges out GoodRx Care with a score of 7.2/10 vs 6.2/10. If budget is your priority, GoodRx Care starts at $119/mo compared to Ro's $149/mo. Choose GoodRx Care if you want: users who want fda-approved brand-name glp-1 access at market-leading subscription pricing — $199/mo wegovy intro, $349/mo standard, plus oral wegovy pill. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither GoodRx Care nor Ro feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review